Risk of Thrombolysis for Stroke After Pretreatment with Aspirin 300 mg

Key Guideline Recommendations

The American Heart Association recommends that aspirin should be delayed until 24 hours after IV alteplase administration to minimize bleeding complications 1
The American College of Cardiology suggests that after the 24-hour delay, aspirin 160-300 mg should be initiated for secondary stroke prevention 1
The American Stroke Association notes that administering aspirin concurrently with or immediately after thrombolysis significantly increases symptomatic intracranial hemorrhage risk and should be avoided for at least 24 hours post-thrombolysis 1

The American Heart Association recommends starting aspirin 160-300 mg within 24-48 hours of stroke onset, providing small but significant reductions in mortality and improved functional outcomes 1, 2
The American College of Cardiology suggests holding all antiplatelet agents until 24 hours post-thrombolysis, and then initiating aspirin 160-300 mg for secondary prevention 1

The American Heart Association notes that earlier guidelines from 2003 reported an unacceptably high incidence of early mortality and intracranial hemorrhage when combining aspirin with thrombolytic agents 3
The International Stroke Trial and Chinese Acute Stroke Trial established aspirin's benefit in acute stroke, demonstrating a 0.1% absolute increase in intracranial hemorrhage even without thrombolysis 2, 3

The American College of Chest Physicians recommends early aspirin (160-325 mg) within 48 hours for acute ischemic stroke, but this is for patients NOT receiving thrombolysis 4, 5
For patients receiving IV alteplase, antiplatelet agents should be delayed until after the 24-hour post-thrombolysis scan has excluded intracranial hemorrhage 6

Aspirin 300 mg given as standard acute stroke treatment (160-300 mg within 24-48 hours) is not a contraindication for mechanical thrombectomy, reflecting different risk-benefit considerations than IV thrombolysis 7

The American College of Cardiology recommends that aspirin should be administered within 24-48 hours of symptom onset after CT excludes hemorrhage, which prevents approximately 5 deaths per 1,000 patients treated through reduction of early recurrent ischemic stroke 8, 9

Aspirin's irreversible inhibition of platelet cyclooxygenase persists for the platelet lifespan (7-10 days), creating a sustained antihemostatic effect, according to the Journal of the American College of Cardiology 10